search
Back to results

Trial of Ultrasound Guided Carpal Tunnel Release Versus Traditional Open Release (TUTOR) (TUTOR)

Primary Purpose

Carpal Tunnel Syndrome, CTS, Carpal Tunnel

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
CTR-US
mOCTR
Sponsored by
Sonex Health, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Carpal Tunnel Syndrome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. ≥18 years of age
  2. Clinical diagnosis of unilateral or bilateral idiopathic CTS
  3. CTS-6 score >12 in target hand
  4. Absence of carpal tunnel symptoms in the contralateral hand that interfere with normal daily activities or work at the time of consent and are not anticipated to interfere with return to activities or return to work within at least 3 months post-operatively
  5. Median nerve cross-sectional area ≥10 mm2 in the proximal carpal tunnel region of the target hand measured by diagnostic ultrasound
  6. Prior failure of one or more nonsurgical treatment options for the target hand (e.g., physical activity modification, bracing, splinting, corticosteroid injection)
  7. Subject agrees to complete follow-up questionnaires over a 12-month period
  8. Subject has a valid mobile phone number and email address to receive and answer follow-up questionnaires

Exclusion Criteria:

  1. Prior surgery on the target wrist or hand with the exception of trigger finger that has clinically recovered
  2. History of prior surgical CTR procedure in the target hand
  3. History of prior surgical CTR in the contralateral hand within 3 months of enrollment or with persistent symptoms that interfere with normal daily activities or work at the time of consent
  4. Corticosteroid injection in the target wrist or hand within 6 weeks of randomization
  5. Presence of additional process in the target wrist or hand requiring additional intervention beyond carpal tunnel release (e.g. neurolysis, mass removal, tenosynovectomy)
  6. Clinically significant degenerative arthritis of the upper limb (shoulder to hand) on the target side
  7. Clinically significant inflammatory disease (including tenosynovitis) of the upper limb (shoulder to hand) on the target side
  8. Clinically significant trauma or deformity of the upper limb (shoulder to hand) on the target side
  9. Clinically significant vascular disease (including Raynaud's phenomenon) of the upper limb (shoulder to hand) on the target side
  10. Clinically significant neurological disorder (including complex regional pain syndrome) of the upper limb (shoulder to hand) on the target side
  11. Planned surgical or interventional procedure on the contralateral wrist or hand
  12. Systemic inflammatory disease (e.g., rheumatoid arthritis, lupus)
  13. Amyloidosis
  14. Chronic renal insufficiency requiring dialysis
  15. Diabetes not controlled by a stable dose of medication over the past three months
  16. Uncontrolled thyroid disease
  17. Pregnant or planning pregnancy in the next 12 months
  18. Workers compensation subjects
  19. Inability to provide a legally acceptable Informed Consent Form and/or comply with all follow-up requirements
  20. Subject has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations

Sites / Locations

  • Sierra Orthopedic Institute
  • Orthopedic Associates
  • Tri-State Orthopaedics
  • Indiana Hand to Shoulder
  • Kansas Orthopaedic Center
  • Massachusetts General Hospital
  • Twin Cities Orthopedics
  • University of Mississippi
  • Midwest Orthopedic Group
  • Sano Orthopedics
  • Washington University
  • ATX Orthopedics

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Carpal Tunnel Release with Ultrasound Guidance (CTR-US)

Mini Open Carpel Tunnel Release (mOCTR)

Arm Description

Outcomes

Primary Outcome Measures

Return to normal daily activities within 3 days postoperatively
The time to return to normal daily activities will be defined as the number of days between treatment and the time the subject reports returning to normal daily activities, irrespective of work status.
Time to Return to Work Among Employed Subjects
The time to return to work will be defined as the number of days between treatment and the time the subject reports returning to work in any capacity.
Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ-SSS) Change
Between-group mean difference in BCTQ-SSS change scores
Boston Carpal Tunnel Questionnaire Functional Status Scale (BCTQ-SSS) Change
Between-group mean difference in BCTQ-FSS change scores
Numeric Pain Scale Change
Between-group mean difference in Numeric Pain Scale change scores. Scoring is 0 to 10, 0 = No pain, 10 = Worst possible pain
EuroQol 5-Dimension 5-Level (EQ-5D-5L) change
Between-group mean difference in EQ-5D-5L change score
Device or Procedure related Adverse Events
Adverse events (AEs) occurring within 90 days of treatment and that are adjudicated as definitely related or probably related to the device, or definitely related or probably related to the procedure will be included in this endpoint. The incidence of device- or procedure-related AEs within 90 days of treatment in each study group will represent a secondary endpoint of the study.

Secondary Outcome Measures

Full Information

First Posted
May 31, 2022
Last Updated
July 6, 2023
Sponsor
Sonex Health, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05405218
Brief Title
Trial of Ultrasound Guided Carpal Tunnel Release Versus Traditional Open Release (TUTOR)
Acronym
TUTOR
Official Title
Trial of Ultrasound Guided Carpal Tunnel Release Versus Traditional Open Release (TUTOR)
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 26, 2022 (Actual)
Primary Completion Date
April 6, 2023 (Actual)
Study Completion Date
April 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sonex Health, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Study to compare the safety and effectiveness of carpal tunnel release with ultrasound guidance (CTR-US) vs. mini-open carpal tunnel release (mOCTR) in patients with symptomatic carpal tunnel syndrome (CTS).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carpal Tunnel Syndrome, CTS, Carpal Tunnel

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Carpal Tunnel Release with Ultrasound Guidance (CTR-US)
Arm Type
Experimental
Arm Title
Mini Open Carpel Tunnel Release (mOCTR)
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
CTR-US
Intervention Description
Carpal Tunnel Release with Ultrasound Guidance
Intervention Type
Procedure
Intervention Name(s)
mOCTR
Intervention Description
Mini Open Carpal Tunnel Release
Primary Outcome Measure Information:
Title
Return to normal daily activities within 3 days postoperatively
Description
The time to return to normal daily activities will be defined as the number of days between treatment and the time the subject reports returning to normal daily activities, irrespective of work status.
Time Frame
3 Month Follow-Up
Title
Time to Return to Work Among Employed Subjects
Description
The time to return to work will be defined as the number of days between treatment and the time the subject reports returning to work in any capacity.
Time Frame
3 Month Follow-Up
Title
Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ-SSS) Change
Description
Between-group mean difference in BCTQ-SSS change scores
Time Frame
3 Month Follow-Up
Title
Boston Carpal Tunnel Questionnaire Functional Status Scale (BCTQ-SSS) Change
Description
Between-group mean difference in BCTQ-FSS change scores
Time Frame
3 Month Follow-Up
Title
Numeric Pain Scale Change
Description
Between-group mean difference in Numeric Pain Scale change scores. Scoring is 0 to 10, 0 = No pain, 10 = Worst possible pain
Time Frame
3 Month Follow-Up
Title
EuroQol 5-Dimension 5-Level (EQ-5D-5L) change
Description
Between-group mean difference in EQ-5D-5L change score
Time Frame
3 Month Follow-Up
Title
Device or Procedure related Adverse Events
Description
Adverse events (AEs) occurring within 90 days of treatment and that are adjudicated as definitely related or probably related to the device, or definitely related or probably related to the procedure will be included in this endpoint. The incidence of device- or procedure-related AEs within 90 days of treatment in each study group will represent a secondary endpoint of the study.
Time Frame
3 Month Follow-Up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥18 years of age Clinical diagnosis of unilateral or bilateral idiopathic CTS CTS-6 score >12 in target hand Absence of carpal tunnel symptoms in the contralateral hand that interfere with normal daily activities or work at the time of consent and are not anticipated to interfere with return to activities or return to work within at least 3 months post-operatively Median nerve cross-sectional area ≥10 mm2 in the proximal carpal tunnel region of the target hand measured by diagnostic ultrasound Prior failure of one or more nonsurgical treatment options for the target hand (e.g., physical activity modification, bracing, splinting, corticosteroid injection) Subject agrees to complete follow-up questionnaires over a 12-month period Subject has a valid mobile phone number and email address to receive and answer follow-up questionnaires Exclusion Criteria: Prior surgery on the target wrist or hand with the exception of trigger finger that has clinically recovered History of prior surgical CTR procedure in the target hand History of prior surgical CTR in the contralateral hand within 3 months of enrollment or with persistent symptoms that interfere with normal daily activities or work at the time of consent Corticosteroid injection in the target wrist or hand within 6 weeks of study procedure date Presence of additional process in the target wrist or hand requiring additional intervention beyond carpal tunnel release (e.g. neurolysis, mass removal, tenosynovectomy) Clinically significant degenerative arthritis of the upper limb (shoulder to hand) on the target side Clinically significant inflammatory disease (including tenosynovitis) of the upper limb (shoulder to hand) on the target side Clinically significant trauma or deformity of the upper limb (shoulder to hand) on the target side Clinically significant vascular disease (including Raynaud's phenomenon) of the upper limb (shoulder to hand) on the target side Clinically significant neurological disorder (including complex regional pain syndrome) of the upper limb (shoulder to hand) on the target side Planned surgical or interventional procedure on the contralateral wrist or hand Systemic inflammatory disease (e.g., rheumatoid arthritis, lupus) Amyloidosis Chronic renal insufficiency requiring dialysis Diabetes not controlled by a stable dose of medication over the past three months Uncontrolled thyroid disease Pregnant or planning pregnancy in the next 12 months Workers compensation subjects Inability to provide a legally acceptable Informed Consent Form and/or comply with all follow-up requirements Subject has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kyle Eberlin, MD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sierra Orthopedic Institute
City
Sonora
State/Province
California
ZIP/Postal Code
95370
Country
United States
Facility Name
Orthopedic Associates
City
Fort Walton Beach
State/Province
Florida
ZIP/Postal Code
32547
Country
United States
Facility Name
Tri-State Orthopaedics
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47715
Country
United States
Facility Name
Indiana Hand to Shoulder
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46260
Country
United States
Facility Name
Kansas Orthopaedic Center
City
Wichita
State/Province
Kansas
ZIP/Postal Code
67205
Country
United States
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
Facility Name
Twin Cities Orthopedics
City
Plymouth
State/Province
Minnesota
ZIP/Postal Code
55441
Country
United States
Facility Name
University of Mississippi
City
Jackson
State/Province
Mississippi
ZIP/Postal Code
39216
Country
United States
Facility Name
Midwest Orthopedic Group
City
Farmington
State/Province
Missouri
ZIP/Postal Code
63640
Country
United States
Facility Name
Sano Orthopedics
City
Lee's Summit
State/Province
Missouri
ZIP/Postal Code
64064
Country
United States
Facility Name
Washington University
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63129
Country
United States
Facility Name
ATX Orthopedics
City
Austin
State/Province
Texas
ZIP/Postal Code
78756
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
36254038
Citation
Eberlin KR, Dy CJ, Fischer MD, Gluck JL, Kaplan FTD, McDonald TJ, Miller LE, Palmer A, Walker ME, Watt JF. Trial of ultrasound guided carpal tunnel release versus traditional open release (TUTOR). Medicine (Baltimore). 2022 Oct 14;101(41):e30775. doi: 10.1097/MD.0000000000030775.
Results Reference
derived

Learn more about this trial

Trial of Ultrasound Guided Carpal Tunnel Release Versus Traditional Open Release (TUTOR)

We'll reach out to this number within 24 hrs